Gene | Position, mb | Description | Reproductive or inflammatory phenotypes of mutation |
---|---|---|---|
Ngfr | 95.430132 – 95.449049 | Nerve growth factor receptor | Perinatal lethality |
Phb | 95.5528271 – 95.542087 | Prohibitin | Lethality before weaning |
Igf2bp1 | 95.818477 – 95.867254 | Insulin-like growth factor 2 | Fetal growth |
Med24 | 96.565905 – 98.590749 | Mediator complex subunit 24 | Pups die prior to birth |
Gsdm3 | 98.490658 – 98.499540 | Gasdermin | Abnormal loss of skin and hair |
Etv4 | 101.631061 – 101.646685 | Ets variant gene 4 (E1A enhancer-binding protein, E1AF) | Mammary gland abnormality, male infertility |
Cd79b a | 106.172655 – 106.176076 | CD79B antigen | Hematopoietic, immune |
Prkar1a | 109.510719 – 109.530970 | Protein kinase, cAMP-dependent regulatory, type I, alpha | Embryonic lethality |
Abca8a a | 109.886948 – 109.957292 | ATP-binding cassette, sub-family A (ABC1), member 8a | Not known |
Map2k6 a | 110.260436 – 110.386836 | Mitogen-activated protein kinase kinase 6 | Abnormal immune system |
Sox9 | 112.643538 – 112.649074 | SRY-box containing gene 9 | Perinatal lethality, cartilage formation, sex reversal |